Fernando Laņas - Concepedia

Author

Fernando Laņas

Also Known As

A Lanas, A. Lanas, ANGEL LANAS, Angel Lanas, Dinesh Mistry, Dominiczak, Anna, Eva M. Lonn, F Lanas, F T Lanas, F. Falcone Lanas Lanas

470

Publications

52.9K

Citations

H-Index

186

Concepts

All Affiliations

Universidad de La Frontera Population Health Research Institute McMaster University Hamilton Health Sciences Estudios Clínicos Latinoamérica

About

Fernando Laņas is an author at Universidad de La Frontera specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	48	24.8K
2	Health Sciences	6	6	727
3	Engineering	3	3	137
4	Business	2	2	88
5	Natural Sciences	1	1	10

Fernando Laņas

171

Publications

46.8K

Citations

H-Index

Page 1

	Year	Citations
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Salim Yusuf, Steven Hawken, Stephanie Ôunpuu, The Lancet Cardiovascular EpidemiologyCardiovascular DiseaseDisease Risk AssessmentGlobal HealthInterheart Study	2004	11.8K
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Apixaban in Patients with Atrial Fibrillation Stuart J. Connolly, John W. Eikelboom, Campbell Joyner, New England Journal of Medicine	2011	2.4K
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, New England Journal of Medicine	2017	2.3K
Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study Martin O’Donnell, Siu Lim Chin, Sumathy Rangarajan, The Lancet Cerebrovascular DiseaseCase-control StudyThrombosisStrokePrevalence	2016	2.1K
Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study Salim Yusuf, Philip Joseph, Sumathy Rangarajan, The Lancet Epidemiological TrendCardiovascular EpidemiologyCardiovascular DiseaseModifiable Risk FactorsDisease Risk Assessment	2019	1.9K
Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study Mahshid Dehghan, Andrew Mente, Xiaohe Zhang, The Lancet ObesityMetabolic SyndromeNutritionNutritional EpidemiologyCardiovascular Epidemiology	2017	1.1K
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey Salim Yusuf, Shofiqul Islam, Clara K Chow, The Lancet Pure StudyHypertensionNon-pharmacological InterventionPreventive MedicineCardiovascular Epidemiology	2011	974
Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries Salim Yusuf, Sumathy Rangarajan, Koon Teo, New England Journal of Medicine	2014	966
Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events Martin O’Donnell, Andrew Mente, Sumathy Rangarajan, New England Journal of Medicine	2014	881

Page 1